脳マッピング装置市場：製品タイプ別、エンドユーザー別-2025-2030年の世界予測

脳マッピング装置市場は、2023年に15億4,000万米ドルと評価され、2024年には17億5,000万米ドルに達すると予測され、CAGR 13.97％で成長し、2030年には38億5,000万米ドルに達すると予測されています。

脳マッピング装置の対象範囲には、脳の活動や機能をマッピングするためのツールや技術が含まれ、神経科学、心理学、医療診断において重要な役割を果たしています。広義には、脳波計（EEG）、脳磁図（MEG）、機能的磁気共鳴画像法（fMRI）、近赤外分光法（NIRS）などが含まれ、これらは電気活動、磁場、血流、ヘモグロビン濃度などを検出することで脳活動を測定します。これらの機器が必要なのは、脳機能の理解、神経疾患の診断、効果的な治療計画の立案に極めて重要な用途があるからです。臨床の場では、手術前の評価に不可欠であり、研究の場では、認知神経科学の知識を向上させる。エンドユーザーは主に病院、診断センター、学術機関、研究機関などです。市場成長の大きな原動力は、神経疾患の有病率の増加と神経技術の進歩であり、ヘルスケア支出の増加と個別化医療の重視の高まりが相まっています。ポータブルで非侵襲的、かつ費用対効果の高いデバイスを開発することで、ホームベースの健康モニタリングなど、臨床現場以外でのアクセシビリティとアプリケーションを拡大することにビジネスチャンスがあります。さらに、人工知能と機械学習を統合することで、データ分析を強化し、個別化された洞察を提供することができます。しかし、市場の拡大は、高コスト、技術的な複雑さ、熟練した専門家の限られた利用可能性などの制限に直面し、低所得地域での採用率に影響を与えています。特にデータのプライバシーや解釈に関する技術的・倫理的課題も障壁となっています。成長に拍車をかけるためには、技術革新は信号分解能の向上、使い勝手の向上、コストの削減に焦点を当てる必要があります。クラウドベースのデータ管理ソリューションを取り入れることで、患者のプライバシーを保護しつつ、遠隔地からのデータ共有と分析を効率化できます。特にAIの統合やウェアラブル技術の継続的な進歩により、脳マッピング装置の市場は、認知機能強化やブレインコンピュータインターフェイスなど、医療と非医療の両領域における需要の高まりに牽引され、研究、開発、商業化の豊富な機会を浮き彫りにする有望な軌道を描いています。

市場力学：急速に進化する脳マッピング装置市場の主要市場インサイトを公開

脳マッピング装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • アルツハイマーや認知症などの脳障害の発生率の上昇
  • 神経疾患治療のための新技術の高い採用率
  • 機器の技術強化
• 市場抑制要因
  • 機器に関連する高コスト
• 市場機会
  • 継続的に変化する需要に対応するための脳マッピング装置の研究開発と改良
  • 高度なヘルスケア技術を利用するための資金/助成金による政府の支援
• 市場の課題
  • 遠隔地や発展途上地域での限定的なリーチ

ポーターの5つの力：脳マッピング装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、脳マッピング装置市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：脳マッピング装置市場における外部からの影響の把握

外部マクロ環境要因は、脳マッピング装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析脳マッピング装置市場における競合情勢の把握

脳マッピング装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス脳マッピング装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、脳マッピング装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨脳マッピング装置市場における成功への道筋を描く

脳マッピング装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • アルツハイマー病や認知症などの脳疾患の発症率の上昇
    • 神経疾患治療における新技術の採用率の高さ
    • 機器の技術的向上
  • 抑制要因
    • デバイスに関連する高コスト
  • 機会
    • 絶えず変化する需要に応えるための脳マッピング装置の研究開発と改善
    • 先進的なヘルスケア技術を利用するための資金/助成金による政府の支援
  • 課題
    • 遠隔地や発展途上地域では到達範囲が限られている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 脳マッピング装置市場：製品タイプ別

• コンピュータ断層撮影
• 脳波検査
• 機能的磁気共鳴画像
• 機能的近赤外分光法
• 脳磁図
• 陽電子放出断層撮影

第7章 脳マッピング装置市場：エンドユーザー別

• 診断センター
• 病院

第8章 南北アメリカの脳マッピング装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の脳マッピング装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの脳マッピング装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advanced Brain Monitoring, Inc
• Brainlab AG
• Ceribell, Inc.
• Cognionics, Inc.
• Compumedics Limited
• Dragerwerk AG
• Edwards Lifesciences Corporation
• Federal Electronics
• General Electric Company
• Koninklijke Philips N.V.
• Masimo Corporation
• Medtronic PLC
• Natus Medical Incorporated by ArchiMed Group
• NeuroLogica Corp. by Samsung Electronics Co., Ltd.
• Neurosoft
• Nihon Kohden Corporation
• NordicNeuroLab AS
• Rimed Ltd. by Unilabs AB
• RYOEI
• SCANCO Medical AG
• Shimadzu Corporation
• Siemens Healthineers AG
• Spiegelberg Gmbh & Co. Kg. by Luciole Medical AG
• TomoTherapy Incorporated by Accuray Incorporated
• Xoran Technologies, LLC

LIST OF FIGURES

• FIGURE 1. BRAIN MAPPING INSTRUMENTS MARKET RESEARCH PROCESS
• FIGURE 2. BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BRAIN MAPPING INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BRAIN MAPPING INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BRAIN MAPPING INSTRUMENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BRAIN MAPPING INSTRUMENTS MARKET DYNAMICS
• TABLE 7. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COMPUTED AXIAL TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FUNCTIONAL MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY FUNCTIONAL NEAR-INFRARED SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. CANADA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. CANADA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CHINA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CHINA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. INDIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. ITALY BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. ITALY BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. POLAND BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. POLAND BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. QATAR BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. QATAR BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM BRAIN MAPPING INSTRUMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. BRAIN MAPPING INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 104. BRAIN MAPPING INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Brain Mapping Instruments Market was valued at USD 1.54 billion in 2023, expected to reach USD 1.75 billion in 2024, and is projected to grow at a CAGR of 13.97%, to USD 3.85 billion by 2030.

The scope of brain mapping instruments encompasses tools and technologies for mapping brain activity and function, playing a vital role in neuroscience, psychology, and medical diagnostics. Defined broadly, these instruments include electroencephalography (EEG), magnetoencephalography (MEG), functional magnetic resonance imaging (fMRI), and near-infrared spectroscopy (NIRS), which measure brain activity by detecting electrical activity, magnetic fields, blood flow, and hemoglobin levels. The necessity of these instruments stems from their crucial applications in understanding brain functions, diagnosing neurological disorders, and developing effective treatment plans. In clinical settings, they are essential for pre-surgical evaluations, while in research, they advance knowledge in cognitive neuroscience. End-users predominantly include hospitals, diagnostic centers, academic institutes, and research organizations. Market growth is significantly driven by an increasing prevalence of neurological disorders and advancements in neurotechnology, coupled with rising healthcare expenditures and a growing emphasis on personalized medicine. Opportunities lie in developing portable, non-invasive, and cost-effective devices to expand accessibility and applications beyond clinical settings, such as home-based health monitoring. Furthermore, integrating artificial intelligence and machine learning can enhance data analysis and offer personalized insights. However, market expansion faces limitations such as high costs, technical complexities, and limited availability of skilled professionals, impacting adoption rates in low-income regions. Technological and ethical challenges, particularly regarding data privacy and interpretation, also pose barriers. To spur growth, innovation must focus on improving signal resolution, enhancing user-friendliness, and reducing costs. Incorporating cloud-based data management solutions could streamline remote data sharing and analysis while protecting patient privacy. With continuous advancements, particularly in AI integration and wearable technology, the market for brain mapping instruments has a promising trajectory, driven by growing demand in both medical and non-medical domains, such as cognitive enhancement and brain-computer interfaces, highlighting rich opportunities for research, development, and commercialization.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brain Mapping Instruments Market

The Brain Mapping Instruments Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of brain disorders such as Alzheimer's or dementia
  • High adoption of new technologies for neurological disease treatments
  • Technological enhancement of instruments
• Market Restraints
  • High cost associated with devices
• Market Opportunities
  • R&D and improvements in the brain mapping instruments to meet to continuously changing demand
  • Government support through funding/grants to avail advanced healthcare technologies
• Market Challenges
  • Limited reach in remote and developing areas

Porter's Five Forces: A Strategic Tool for Navigating the Brain Mapping Instruments Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brain Mapping Instruments Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brain Mapping Instruments Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brain Mapping Instruments Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brain Mapping Instruments Market

A detailed market share analysis in the Brain Mapping Instruments Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brain Mapping Instruments Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brain Mapping Instruments Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brain Mapping Instruments Market

A strategic analysis of the Brain Mapping Instruments Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Mapping Instruments Market, highlighting leading vendors and their innovative profiles. These include Advanced Brain Monitoring, Inc, Brainlab AG, Ceribell, Inc., Cognionics, Inc., Compumedics Limited, Dragerwerk AG, Edwards Lifesciences Corporation, Federal Electronics, General Electric Company, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Natus Medical Incorporated by ArchiMed Group, NeuroLogica Corp. by Samsung Electronics Co., Ltd., Neurosoft, Nihon Kohden Corporation, NordicNeuroLab AS, Rimed Ltd. by Unilabs AB, RYOEI, SCANCO Medical AG, Shimadzu Corporation, Siemens Healthineers AG, Spiegelberg Gmbh & Co. Kg. by Luciole Medical AG, TomoTherapy Incorporated by Accuray Incorporated, and Xoran Technologies, LLC.

Market Segmentation & Coverage

This research report categorizes the Brain Mapping Instruments Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Computed Axial Tomography, Electroencephalography, Functional Magnetic Resonance Imaging, Functional Near-Infrared Spectroscopy, Magnetoencephalography, and Positron Emission Tomography.
• Based on End-User, market is studied across Diagnostic Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of brain disorders such as Alzheimer's or dementia
    • 5.1.1.2. High adoption of new technologies for neurological disease treatments
    • 5.1.1.3. Technological enhancement of instruments
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with devices
  • 5.1.3. Opportunities
    • 5.1.3.1. R&D and improvements in the brain mapping instruments to meet to continuously changing demand
    • 5.1.3.2. Government support through funding/grants to avail advanced healthcare technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Limited reach in remote and developing areas
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Brain Mapping Instruments Market, by Product Type

• 6.1. Introduction
• 6.2. Computed Axial Tomography
• 6.3. Electroencephalography
• 6.4. Functional Magnetic Resonance Imaging
• 6.5. Functional Near-Infrared Spectroscopy
• 6.6. Magnetoencephalography
• 6.7. Positron Emission Tomography

7. Brain Mapping Instruments Market, by End-User

• 7.1. Introduction
• 7.2. Diagnostic Centers
• 7.3. Hospitals

8. Americas Brain Mapping Instruments Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Brain Mapping Instruments Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Brain Mapping Instruments Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Brain Monitoring, Inc
• 2. Brainlab AG
• 3. Ceribell, Inc.
• 4. Cognionics, Inc.
• 5. Compumedics Limited
• 6. Dragerwerk AG
• 7. Edwards Lifesciences Corporation
• 8. Federal Electronics
• 9. General Electric Company
• 10. Koninklijke Philips N.V.
• 11. Masimo Corporation
• 12. Medtronic PLC
• 13. Natus Medical Incorporated by ArchiMed Group
• 14. NeuroLogica Corp. by Samsung Electronics Co., Ltd.
• 15. Neurosoft
• 16. Nihon Kohden Corporation
• 17. NordicNeuroLab AS
• 18. Rimed Ltd. by Unilabs AB
• 19. RYOEI
• 20. SCANCO Medical AG
• 21. Shimadzu Corporation
• 22. Siemens Healthineers AG
• 23. Spiegelberg Gmbh & Co. Kg. by Luciole Medical AG
• 24. TomoTherapy Incorporated by Accuray Incorporated
• 25. Xoran Technologies, LLC